metricas
covid
Annals of Hepatology Clinical and epidemiologic characteristics of pregnant women with liver disease ...
Journal Information
Vol. 30. Issue S1.
Abstracts Asociación Mexicana de Hepatología (AMH) 2024
(April 2025)
Vol. 30. Issue S1.
Abstracts Asociación Mexicana de Hepatología (AMH) 2024
(April 2025)
Full text access
Clinical and epidemiologic characteristics of pregnant women with liver disease in a tertiary hospital.
Visits
303
Yelba G. Céspedes-Saballos1, Diego F. Abendaño-Rivera1, Vilma Hernández-Garza1, Deborah E. Espinoza-López1, Viridiana López-Ladrón de Guevara1, Santiago Camacho-Hernández2, Fátima Higuera-de-la-Tijera1
1 Department of Gastroenterology and Hepatology, General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City, Mexico
2 Research Department, General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City, Mexico
This item has received
Article information
Abstract
Full Text
Download PDF
Statistics
Tables (1)
Tables
Special issue
This article is part of special issue:
Vol. 30. Issue S1

Abstracts Asociación Mexicana de Hepatología (AMH) 2024

More info
Introduction and Objectives

It has been demonstrated that approximately 3% of pregnant women are affected by some type of liver disorder. The aim of this study is to determine the clinical and epidemiological characteristics of pregnant patients who developed liver disease during their pregnancy or liver pathology unrelated to pregnancy.

Materials and Patients

The study is a retrospective and observational analysis of a cohort composed of 72 pregnant women diagnosed with liver pathologies. These patients were seen in the gynecology and obstetrics service of the Hospital General de México between January 2023 and May 2024. The selection of the participants was based on their admission during the aforementioned period and the presence of a diagnosis of liver disease associated with pregnancy or under investigation. Data collection was carried out using forms designed for this purpose, through the review of the patients' clinical records, which classifies the source of information as secondary. Data analysis was performed using SPSS statistical software version 23. A descriptive approach was used for the analysis, presenting qualitative variables in terms of frequency and percentage, while measures of central tendency, such as mean and standard deviation, were calculated for quantitative variables.

Results

Data were collected from 72 files of pregnant patients who developed liver disease during pregnancy or liver pathology unrelated to pregnancy. The average age was 28.36, 28.36+-6.96 (26.75-29.97). 66.7% were multipregnant and 31.9% were primigravida. Regarding associated comorbidities, 59.7% did not present any comorbidity, while 40.3% presented some comorbidity, with subclinical hypothyroidism being the most frequent at 9.7%. Regarding nutritional status, 40.3% were obese, 6.9% overweight, and 27.8% normal weight. In the viral panel, 30.6% were non-reactive for HAV, HBV, and HCV, and up to 65.3% were not tested. Imaging studies showed the absence of intra- and extra-hepatic duct dilatation in 25%, on the other hand, 31.1% did not undergo imaging studies. The 87.5% presented some pathology related to pregnancy, the main ones being intrahepatic cholestasis (30.6%), preeclampsia with severe features (27.8%), HELLP syndrome (18.1%), and only 13.9% pathologies not related to pregnancy, the main ones being metabolic hepatic steatosis (5.6%) and viral hepatitis (2.8%).

Conclusions

In our study, liver pathology in pregnant women has similar characteristics to those reported in the world literature, with those related to pregnancy predominating over pre-existing pathologies. It should be emphasized that all pregnant women should be approached for such pathology and thus avoid complications in both mother and child.

Full Text

Ethical statement: The research was conducted in accordance with the Helsinki Declaration (2013 revision).

Declaration of interests: None.

Funding: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Characteristics  n=72
Sociodemographic
Mean age (in years) (± SD)28 
OccupationUnemployed  64  88.9 
Employee  11.1 
Scholarshipprimary  1.4 
Secondary  31  43.1 
Superior  40  55.6 
Civil statusWith partner  57  79.1 
Single  15  20.8 
Comorbidities
Subclinical hypothyroidism9.7 
Gestational diabetes5.6 
Gestational hypertension8.3 
Subclinical hypothyroidism + gestational diabetes6.9 
None43  59.7 
Nutritional condition
Malnutrition17  23.6 
Overweight6.9 
Obesity3. 4  47.2 
Normal weight27.8 
Deeds
Multiple pregnancies48  66.7 
First pregnancy23  31.9 
viral panel
VHA2.8 
HCV1.4 
Non-reactive to HAV, HBV, HCV22  30.6 
Not performed47  65.3 
Image study
Without dilation of the intra- and extra-hepatic pathway18  25.0 
Reactive cholecystitis without signs of exacerbation, without bile duct dilation9.7 
Not performed31  43.1 
Pathologies related to pregnancy n= 63 87. 5 %
Hyperemesis gravidarum8.3 
intrahepatic cholestasis22  30.6 
Pre-eclampsia with severity data20  27 . 8 
Hellp syndrome1 3  18.1 
Eclampsia1.4 
Pregnancy fatty liver1.4 
Pathologies not related to pregnancy n=9 12.5%
Hepatic cirrhosis1.4 
viral hepatitis2.8 
Probable autoimmune liver disease1.4 
Metabolic hepatic steatosis5.6 
Polycystic liver disease1.4 

DM, Diabetes mellitus; HAV, Hepatitis A virus; HBV, Hepatitis B virus; HCV, Hepatitis C virus.

Download PDF
Article options
Tools